middle.news
Avecho Secures US and European Patents Ahead of Major CBD Insomnia Trial Results
11:51am on Wednesday 3rd of December, 2025 AEDT
•
Biotechnology
Read Story
Avecho Secures US and European Patents Ahead of Major CBD Insomnia Trial Results
11:51am on Wednesday 3rd of December, 2025 AEDT
Key Points
US and European patents allowed for Avecho’s CBD TPM soft-gel capsule
Patents expected to be granted by end of FY26, protecting formulation until 2040
Phase III clinical trial underway for insomnia treatment, largest global CBD insomnia study
Interim Phase III results anticipated in H1 2026
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Avecho Biotechnology (ASX:AVE)
OPEN ARTICLE